Qiagen NV is a global leader in providing comprehensive solutions that convert biological materials into valuable molecular insights. Founded in 1986 and based in Venlo, the Netherlands, Qiagen serves a wide range of customers in molecular diagnostics, academia, pharmaceuticals, and applied testing. The company's offerings include a variety of consumables and instruments for nucleic acid purification, genotyping, gene expression analysis, and more. Qiagen also specializes in assays for a range of applications, from prenatal testing to infectious disease detection and forensic analysis, complemented by powerful bioinformatics solutions.
Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter…
Pre-Market Stock Futures: The futures are trading mixed this morning, after what started as another week of the same old song and dance yesterday, before stocks turned around before noon, and it…
Wednesday's top analyst upgrades and downgrades included CVS Health, DataDog, Endeavor, Enphase Energy, Extreme Networks, GitLab, Nvidia, RTX, Splunk and United Parcel Service.
Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and Shopify.
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack, Ventas and Zscaler.
The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack and Wingstop.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
Thursday's top analyst upgrades, downgrades and initiations include AMAG Pharmaceuticals, Devon Energy, eBay, Freshpet, Range Resources, Raytheon, SeaWorld and Zynga.
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.
U.S. equity markets opened slightly higher this morning following the report on U.S. jobless numbers (more coverage here). In Europe, the only data out today showed that U.K. retail sales fell 0.7%,…
Jon OggWhile investors generally see analysts issuing Buy ratings, it is always interesting to see what happens when Wall St. analysts give stocks to sell or when they have very cautious comments…
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed very well…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Apple Inc. (NASDAQ: AAPL) cut to Neutral and target cut to $575…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Amazon.com Inc. (NASDAQ: AMZN) Started as Neutral at Collins Stewart. Baidu,…
